DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
Vanessa Lakis(The University of Queensland), Nick Pavlakis(Royal North Shore Hospital), Max Nobis(Garvan Institute of Medical Research), Massimo Milione(Fondazione IRCCS Istituto Nazionale dei Tumori), Tanya Dwarte(Garvan Institute of Medical Research), David K. Chang(University of Glasgow), Andrea Mafficini(University of Verona), Xanthe L. Metcalf(Garvan Institute of Medical Research), Claire Vennin(Garvan Institute of Medical Research), Pamela Mukhopadhyay(QIMR Berghofer Medical Research Institute), Michèle Milella(National Cancer Institute), Sara Cingarlini, Vincenzo Corbo(University of Verona), Ann‐Marie Patch(QIMR Berghofer Medical Research Institute), Marie‐Claude Gingras(Baylor College of Medicine), Donna M. Muzny(Baylor College of Medicine), Borislav C. Rusev(University of Verona), Rita T. Lawlor(University of Verona), Daniel A. Reed(Garvan Institute of Medical Research), Conrad Leonard(QIMR Berghofer Medical Research Institute), Scott Wood(The University of Queensland), Anguraj Sadanandam(Institute of Cancer Research), Claudio Luchini(University of Verona), Richard A. Gibbs(Baylor College of Medicine), Luca Landoni(University of Verona), Paul Timpson(Garvan Institute of Medical Research), Felicity Newell(QIMR Berghofer Medical Research Institute), Roberto Salvia(University of Verona), Venkateswar Addala(QIMR Berghofer Medical Research Institute), Nigel B. Jamieson(University of Glasgow), Lambros T. Koufariotis(QIMR Berghofer Medical Research Institute), Marina Pajic(University of Glasgow), Stephen H. Kazakoff(QIMR Berghofer Medical Research Institute), Oliver Hofmann(The University of Melbourne), Cecilia R. Chambers(Garvan Institute of Medical Research), Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Brooke Pereira(Garvan Institute of Medical Research), Fraser R. Duthie(NHS Greater Glasgow and Clyde), Peter J. Bailey(Cambridge University Hospitals NHS Foundation Trust), David Hermann(Garvan Institute of Medical Research), Shona Ritchie(Garvan Institute of Medical Research), Thomas R. Cox(Garvan Institute of Medical Research), Qinying Xu(The University of Melbourne), Lorraine A. Chantrill(Garvan Institute of Medical Research), Angela Murphy(Garvan Institute of Medical Research), Angela Chou(Royal North Shore Hospital), Oliver Holmes(QIMR Berghofer Medical Research Institute), David A. Wheeler(Baylor College of Medicine)
Cited by 54
Related Papers
A global reference for human genetic variation
|Nature|2015|20.3k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k